NZYM-B.CO

Novozymes A/S [NZYM-B.CO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

NZYM-B.CO Stock Summary

Top 10 Correlated ETFs

NZYM-B.CO


Top 10 Correlated Stocks

NZYM-B.CO


In the News

NZYM-B.CO Financial details

Company Rating
Strong Buy
Market Cap
184.54B
Income
3.02B
Revenue
17.9B
Book val./share
-
Cash/share
-
Dividend
10.2
Dividend %
2.79%
Employees
6.4K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
31.58
Forward P/E
26.78
PEG
-8.65
P/S
5.69
P/B
7
P/C
-
P/FCF
80.31
Quick Ratio
0.19
Current Ratio
1.52
Debt / Equity
0.03
LT Debt / Equity
0.02
-
-
EPS (TTM)
8.4
EPS next Y
14.84
EPS next Q
-
EPS this Y
-17.46%
EPS next Y
76.68%
EPS next 5Y
76.68%
EPS last 5Y
-0.25%
Revenue last 5Y
4.48%
Revenue Q/Q
3.3%
EPS Q/Q
-
-
-
-
-
SMA20
5.43%
SMA50
13.33%
SMA100
26.71%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
24%
ROC
0.2%
Gross Margin
54%
Oper. Margin
26%
Profit Margin
18%
Payout
52%
Shs Outstand
464.36M
Shs Float
352.81M
-
-
-
-
Target Price
-
52W Range
274.6-400.3
52W High
-0.65%
52W Low
+45.04%
RSI
50
Rel Volume
1.04
Avg Volume
623.05K
Volume
646.12K
Perf Week
-2.33%
Perf Month
7.58%
Perf Quarter
36.85%
Perf Half Y
37.56%
-
-
-
-
Beta
0.475
-
-
Volatility
6.41%, 12.99%
Prev Close
-2.62%
Price
397.4
Change
-2.29%

NZYM-B.CO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
50.1649.6853.3562.6464.41
Net income per share
11.0110.0211.2313.1210.88
Operating cash flow per share
11.1515.4414.514.314.94
Free cash flow per share
7.6712.1110.073.987.54
Cash per share
2.534.613.744.16
Book value per share
40.0239.8342.249.3850.3
Tangible book value per share
33.3430.8125.6334.0135.34
Share holders equity per share
40.0239.8342.249.3850.3
Interest debt per share
16.7113.612.081.831.95
Market cap
93.42B98.57B150.54B98.61B103.12B
Enterprise value
97.41B101.16B150.06B97.98B102.37B
P/E ratio
29.6234.8947.8526.8334.1
Price to sales ratio
6.57.0310.075.625.76
POCF ratio
29.2322.6337.0624.6224.84
PFCF ratio
42.4828.8653.3488.3649.2
P/B Ratio
8.158.7712.737.137.38
PTB ratio
8.158.7712.737.137.38
EV to sales
6.787.2210.045.585.72
Enterprise value over EBITDA
20.6421.0828.8716.1317.52
EV to operating cash flow
30.4823.2336.9424.4624.66
EV to free cash flow
44.329.6253.1787.848.84
Earnings yield
0.030.030.020.040.03
Free cash flow yield
0.020.030.020.010.02
Debt to equity
0.410.340.040.030.03
Debt to assets
0.230.180.020.010.01
Net debt to EBITDA
0.850.54-0.09-0.1-0.13
Current ratio
1.491.661.381.331.3
Interest coverage
46.9757.9739.2845.3826.31
Income quality
1.011.541.291.091.37
Dividend Yield
0.020.020.010.020.03
Payout ratio
0.460.520.470.410.94
Sales general and administrative to revenue
0.060.050.060.050.05
Research and developement to revenue
0.140.140.130.110.11
Intangibles to total assets
0.090.120.20.170.16
Capex to operating cash flow
-0.31-0.22-0.31-0.72-0.5
Capex to revenue
-0.07-0.07-0.08-0.16-0.11
Capex to depreciation
-0.84-0.74-0.88-1.98-1.48
Stock based compensation to revenue
000.010.010.01
Graham number
99.5694.75103.25120.72110.98
ROIC
0.20.190.250.260.24
Return on tangible assets
0.170.160.160.160.13
Graham Net
-14.61-15.48-25.63-27.21-39.84
Working capital
2.32B2.75B2.15B2.28B2.2B
Tangible asset value
9.55B8.69B7.18B9.53B9.82B
Net current asset value
-1.91B-2.36B-4.74B-4.51B-4.58B
Invested capital
0.410.340.040.030.03
Average receivables
1.82B3.44B3.51B3.97B2.07B
Average payables
1.27B1.11B1.3B1.68B1.74B
Average inventory
2.72B2.49B2.68B3.4B3.72B
Days sales outstanding
92.6684.0692.686.150
Days payables outstanding
63.5165.1985.9485.5372.13
Days of inventory on hand
148.56139.92172.58174.03161.9
Receivables turnover
3.944.343.944.240
Payables turnover
5.755.64.254.275.06
Inventory turnover
2.462.612.112.12.25
ROE
0.280.250.270.270.22
Capex per share
-3.48-3.33-4.42-10.31-7.4

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
16.2716.6415.1716.050
Net income per share
3.172.822.183.370
Operating cash flow per share
2.11.134.075.710
Free cash flow per share
-1.14-0.412.0940
Cash per share
4.034.2644.290
Book value per share
49.746.3648.1752.160
Tangible book value per share
34.2331.2733.2337.190
Share holders equity per share
49.746.3648.1752.160
Interest debt per share
0.111.881.551.350
Market cap
97.97B97.48B88.34B79.06B0
Enterprise value
97.34B96.79B87.69B78.26B-747M
P/E ratio
27.7431.0836.4521.120
Price to sales ratio
21.6321.0920.9517.740
POCF ratio
167.76310.4578.1849.850
PFCF ratio
-310.03-855.09152.0671.160
P/B Ratio
7.087.576.65.460
PTB ratio
7.087.576.65.460
EV to sales
21.4920.9420.7917.56-0.16
Enterprise value over EBITDA
86.9976.4589.358.14-0.72
EV to operating cash flow
166.68308.2577.649.34-0.67
EV to free cash flow
-308.03-849.05150.9370.44-1.44
Earnings yield
0.010.010.010.010
Free cash flow yield
000.010.010
Debt to equity
0.030.030.030.030.03
Debt to assets
0.010.010.010.010.01
Net debt to EBITDA
-0.56-0.54-0.67-0.6-0.72
Current ratio
1.331.351.371.521.3
Interest coverage
-4.0510.2222.76012.76
Income quality
0.670.391.841.711.61
Dividend Yield
00.02000
Payout ratio
02.12001.71
Sales general and administrative to revenue
0.050.050.050.050.05
Research and developement to revenue
0.120.110.120.10.11
Intangibles to total assets
0.170.160.160.160.16
Capex to operating cash flow
-1.54-1.36-0.49-0.3-0.54
Capex to revenue
-0.2-0.09-0.13-0.11-0.13
Capex to depreciation
-2.43-1.2-1.64-1.430
Stock based compensation to revenue
0.020000
Graham number
59.5654.2648.6162.890
ROIC
0.090.060.050.050.08
Return on tangible assets
0.040.030.030.040.03
Graham Net
-27.39-30.49-29.19-26.070
Working capital
2.28B2.48B2.54B3.22B2.2B
Tangible asset value
9.53B8.69B9.24B10.33B9.82B
Net current asset value
-4.51B-5.41B-5.06B-4.21B-4.58B
Invested capital
0.030.030.030.030.03
Average receivables
4.11B4.35B4.43B4.34B2.19B
Average payables
1.84B1.66B1.39B1.39B1.54B
Average inventory
3.78B3.83B3.91B3.92B3.75B
Days sales outstanding
82.3388.791.7988.30
Days payables outstanding
79.8761.6463.2163.8568.67
Days of inventory on hand
162.52163.49189.57169.59154.12
Receivables turnover
1.091.010.981.020
Payables turnover
1.131.461.421.411.31
Inventory turnover
0.550.550.470.530.58
ROE
0.060.060.050.060.05
Capex per share
-3.23-1.54-1.98-1.710

NZYM-B.CO Frequently Asked Questions

What is Novozymes A/S stock symbol ?

Novozymes A/S is a DK stock and trading under the symbol NZYM-B.CO

What is Novozymes A/S stock quote today ?

Novozymes A/S stock price is $397.4 today.

Is Novozymes A/S stock public?

Yes, Novozymes A/S is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks